Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.
about
Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.
description
clinical trial
@en
klinisch onderzoek
@nl
name
Study of Carfilzomib, Daratumu ...... r Refractory Multiple Myeloma.
@en
type
label
Study of Carfilzomib, Daratumu ...... r Refractory Multiple Myeloma.
@en
prefLabel
Study of Carfilzomib, Daratumu ...... r Refractory Multiple Myeloma.
@en
P17
P4844
P1050
P1476
A Randomized, Open-label, Phas ...... ratumumab fOr Relapsed Myeloma
@en
P17
P1813
CANDOR
@en
P3098
NCT03158688
P580
2017-06-13T00:00:00Z
P582
2019-06-24T00:00:00Z